Skip to main content
. Author manuscript; available in PMC: 2024 May 15.
Published in final edited form as: JCO Precis Oncol. 2024 Apr;8:e2300635. doi: 10.1200/PO.23.00635

TABLE A1.

Biomarker Designations and Crossover

Biomarker Characteristic Gemcitabine Alone (n = 36), No. (%) Did Not Cross Over, No. (%) Crossed Over, No. (%) P
RS biomarker
 RS-low 17 (47) 9 (53) 8 (47) .47
 RS-high 13 (36) 9 (69) 4 (31)
 Unknown 6 (17)
Mutational signature 3
 Negative 18 (50) 11 (61) 7 (39) 1
 Positive 12 (33) 7 (58) 5 (42)
 Unknown 6 (17)
ATM expression by IHC
 Negative/low 11 (31) 6 (55) 5 (45) 1
 Positive 20 (56) 11 (55) 9 (45)
 Unknown 5 (14)

Abbreviations: IHC, immunohistochemistry; RS, replication stress.